Research ArticleClinical Investigations
Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans
Adriana Alexandre S. Tavares, Jeffery C. Batis, Caroline Papin, Danna Jennings, David Alagille, David S. Russell, Christine Vala, Hsiaoju Lee, Ronald M. Baldwin, I. George Zubal, Kenneth L. Marek, John P. Seibyl, Olivier Barret and Gilles D. Tamagnan
Journal of Nuclear Medicine October 2013, 54 (10) 1760-1767; DOI: https://doi.org/10.2967/jnumed.113.119933
Adriana Alexandre S. Tavares
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
Jeffery C. Batis
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Caroline Papin
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Danna Jennings
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
David Alagille
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
David S. Russell
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Christine Vala
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Hsiaoju Lee
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Ronald M. Baldwin
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
I. George Zubal
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Kenneth L. Marek
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
John P. Seibyl
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Olivier Barret
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Gilles D. Tamagnan
1Molecular NeuroImaging, LLC, New Haven, Connecticut; and
2Institute for Neurodegenerative Disorders, New Haven, Connecticut
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 10
October 1, 2013
Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans
Adriana Alexandre S. Tavares, Jeffery C. Batis, Caroline Papin, Danna Jennings, David Alagille, David S. Russell, Christine Vala, Hsiaoju Lee, Ronald M. Baldwin, I. George Zubal, Kenneth L. Marek, John P. Seibyl, Olivier Barret, Gilles D. Tamagnan
Journal of Nuclear Medicine Oct 2013, 54 (10) 1760-1767; DOI: 10.2967/jnumed.113.119933
Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans
Adriana Alexandre S. Tavares, Jeffery C. Batis, Caroline Papin, Danna Jennings, David Alagille, David S. Russell, Christine Vala, Hsiaoju Lee, Ronald M. Baldwin, I. George Zubal, Kenneth L. Marek, John P. Seibyl, Olivier Barret, Gilles D. Tamagnan
Journal of Nuclear Medicine Oct 2013, 54 (10) 1760-1767; DOI: 10.2967/jnumed.113.119933